A 50-year-old woman in the U.S. developed secondary cold agglutinin disease (CAD), a rare form of autoimmune anemia, as…
Esteban Dominguez Cerezo, MS
Esteban holds a Master of Science in Immunology from the Instituto Politécnico Nacional in Mexico, focused on inflammation and metabolism. With five years of experience as a Medical Science Liaison, he has worked directly with physicians across a wide range of specialties, covering topics related to biological therapy and vaccines. Esteban is particularly interested in scientific communication as a tool to empower patients and caregivers.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Esteban Dominguez Cerezo, MS
Recordati agreed to acquire the global rights to Enjaymo (sutimlimab), the only approved targeted therapy for cold…